Related Experiment Video
Updated: May 29, 2026
Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Research progress of exosomes in renal ischemia-reperfusion injury
Supeng Tai1,2,3, Weibo Wang1,2,3, Guangyue Luo1,2,3
1Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Abstract:
Renal ischemia-reperfusion injury (RIRI), which causes renal damage that occurs when blood flow is restored after a period of reduced perfusion, is a common cause of acute kidney injury. As the disease progresses, treatment options become increasingly limited, highlighting the urgent need for new therapeutic approaches. Among these, exosomes (Exos) have shown great potential in the prevention and treatment of this condition. Exos are nano-sized vesicles of endosomal origin, typically less than 200 nm in diameter, and have emerged as key mediators in diverse pathophysiological processes. This article provides a comprehensive narrative review of the mechanisms of various types of Exos in renal ischemia-reperfusion injury and the advancements in exosome therapy, and details both their renoprotective mechanisms and potential pathogenic effects. Furthermore, we highlight advanced bioengineering strategies, delivery platforms, and diagnostic potential. By explicitly addressing translational barriers and the need for rigorous methodological standardization, we aim to provide comprehensive insights for advancing exosome-based RIRI management from bench to clinic.
Insights
Exosomes show promise for treating kidney damage from reduced blood flow. This review explores exosome therapy mechanisms, bioengineering, and delivery for renal ischemia-reperfusion injury (RIRI).
Area of Science:
- Nephrology
- Biomedical Engineering
- Regenerative Medicine
Background:
- Renal ischemia-reperfusion injury (RIRI) is a major cause of acute kidney injury with limited treatment options.
- Exosomes (Exos), nano-sized vesicles, are emerging as key mediators in pathophysiological processes and potential therapeutics.
- There is an urgent need for novel therapeutic strategies to manage RIRI effectively.
Purpose of the Study:
- To provide a comprehensive review of exosome mechanisms in RIRI.
- To detail advancements in exosome therapy for RIRI, including renoprotective and pathogenic effects.
- To highlight bioengineering strategies, delivery platforms, and diagnostic potential for exosome-based RIRI management.
Main Methods:
- Narrative review of existing literature on exosomes and RIRI.
- Analysis of exosome renoprotective and pathogenic mechanisms.
- Exploration of bioengineering, delivery systems, and diagnostic applications.
Main Results:
- Exosomes exhibit diverse mechanisms in RIRI, offering both protective and potentially detrimental effects.
- Various bioengineering strategies and delivery platforms are being developed for exosome-based therapies.
- Exosomes hold diagnostic potential for RIRI assessment.
Conclusions:
- Exosome therapy presents a promising avenue for RIRI treatment, with significant potential for clinical translation.
- Addressing translational barriers and standardizing methodologies are crucial for advancing exosome-based RIRI management.
- Further research into bioengineering and delivery is essential to optimize exosome therapeutic applications for RIRI.
